The Pulsenmore was designed to follow ALARA (As Low As Reasonably Achievable) principles as follows:
The system supports only low frequency (2-5MHz), the duration of the scan is limited up to 3 minutes in the App guided mode, or at the clinician’s discretion in the clinician guided mode, only clinician can modify the ultrasound parameters (i.e., depth, gain, frequency etc.), each scan is enabled only upon the approval of a medical professional. The system was authorized by FDA through the de novo classification process.